Under Bernie Sanders's Glare, Pharmaceutical Chiefs Will Testify on Drug Prices
Briefly

The three executives scheduled to testify...are expected to clash with Senator Bernie Sanders...
The hearing comes as a new federal program authorizing Medicare to negotiate the prices of some costly medications is getting underway...
Drug makers, including all three companies that will be represented at the hearing, have filed a flurry of lawsuits arguing that the negotiation program is unconstitutional.
Read at www.nytimes.com
[
add
]
[
|
|
]